BIO 2019 - Browse Agenda

All Sessions

1:00 PM–2:15 PM

Jun 3, 2019

Business Development and Finance

Immuno-oncology Investment: Building Biology

107AB, Level 100

Speakers

SARAH HARDISONTherapeutic Area Director, Immunology & Immuno-oncology atClarivate Analytics

2:30 PM–3:45 PM

Jun 3, 2019

Business Development and Finance

Persuasive Pitching: Do You Have the Talent to Engage Investors?

109AB, Level 100

Speakers

Douglas MacDougallManaging Partner atMacDougall

Lisa GrayManaging Partner atPIPV Capital

Frederick "Rick" ` JonesPartner atBioAdvance

James KasuboskiSenior Director atBoehringer Ingelheim Venture Fund

Dr. Emmanuel LacroixPartner atUCB Ventures

Karen Narolewski EngelPartner atS.R. One

Sara NayeemPartner atNew Enterprise Associates

2:30 PM–3:45 PM

Jun 3, 2019

Business Development and Finance

Powered by BARDA – Innovative Government Models

107AB, Level 100

Speakers

Steve BrozakPresident and Founder atWBB Securities

Phil GolzVice President for Healthcare Strategy and Sales atSpire

Dr. Sam MaldonadoVice President, Head of Child Health Innovation and Leadership Department (CHILD) atJohnson & Johnson

Tyler MerkeleyInterdisciplinary Scientist atBARDA

Thomas RichardsonPresident atInstitute for Life Science Entrepreneurship (ILSE)

Kathryn ZavalaVice President, Operations and Business Development atMedTech Innovator

Zachary ZimmermanCEO atForge Therapeutics Inc.

4:00 PM–5:00 PM

Jun 3, 2019

Business Development and Finance

Leveraging America’s Seed Fund (SBIR/STTR) to Accelerate Life Sciences Technology Development and Secure Follow-On Investments

109AB, Level 100

Speakers

Ashim SubedeeProgram Director atNCI Small Business Innovation Research (SBIR) Development Center

Dr. Matthew PortnoyProgram Manager, NIH SBIR/STTR Program atNational Institutes of Health

Michal PremingerHead, J&J Innovation, East North America atJohnson & Johnson Innovation

Allen ReitzCEO atFox Chase Chemical Diversity Center, Inc.

Stephanie StehmanPrincipal atOsage University Partners

11:00 AM–12:15 PM

Jun 4, 2019

Business Development and Finance

Changing the Game: Breaking Down Barriers and Building Up the Next Generation

107AB, Level 100

Speakers

Mrs. Rachel KingCo-Founder and CEO atGlycoMimetics

Lily CorteseDirector, Transactions atJohnson & Johnson

Arpa GarayPresident of Global Pharma atMerck

Monique Kelley GigliottiDirector, R&D Communications atTakeda Pharmaceutical Company, Ltd.

Ms. Nancy SimonianFounding CEO atSyros

11:00 AM–12:15 PM

Jun 4, 2019

Business Development and Finance

The New World of Life Sciences M&A Valuation: Strategies to Adapt and Thrive

109AB, Level 100

Speakers

Mr. John BabittPartner atEY

John FowlerVice Chairman of Healthcare Investment Banking atWells Fargo Securities, LLC

Douglas GiordanoSenior VP, Worldwide Business Development atPfizer Inc

Evan LippmanHead of Corporate Development and Business Development Finance atTakeda Pharmceuticals

Mr. Joshua SchaferSVP, Business Development & Strategy, and GM, International Operations atMallinckrodt Pharmaceuticals

2:00 PM–3:00 PM

Jun 4, 2019

Business Development and Finance

How Can Biopharma Divest to Innovate?

109AB, Level 100

Speakers

Dr. Arda UralPartner atEY

Anil AsnaniVP atLabCorp

Marianne de backerVP, Global M&A Operations and Divestitures (Pharmaceuticals Group), Global Infectious Diseases & Vaccines Business Development atJohnson & Johnson Innovation

Paris PanayiotopoulosManaging Director atBlackstone Life Sciences

Dr. Kristen SlaouiVP, Head of Business Development, Pharma Commercial atGlaxoSmithKline

2:00 PM–3:00 PM

Jun 4, 2019

Business Development and Finance

The Changing Landscape in Pharma/Diagnostic Partnerships

107AB, Level 100

Speakers

Hakan SakulVice President, Diagnostics atPfizer

Jessica AtkinsonVice President, Corporate and Business Development atFoundation Medicine

Guy GreiveldingerHead of Precision Medicine BD&L atNovartis

Sebastian KronmuellerHead of Molecular Services atSiemens Healthineers

Trevor PageChief Business Officer, Companion Diagnostics atAgilent

3:15 PM–4:15 PM

Jun 4, 2019

Business Development and Finance

Building a Winning Team for Biotech Business Success – Lessons You Can Learn from Industry Veterans and Former NFL Player Turned Broadcaster Solomon Wilcots

107AB, Level 100

Speakers

Solomon WilcotsSports broadcaster and Sports-Health Alliance Leader atSirius XM Inc.; Russo Partners, LLC; Sky Sports UK

Raza BokhariCo-Chairman and Interim CEO atFSD Pharma

Mei Mei HuChief Executive Officer atUnited Neuroscience Ltd.

William NewellChief Executive Officer and Director atSutro Biopharma Inc.

Gil Van BokkelenChairman and CEO atAthersys

3:15 PM–4:15 PM

Jun 4, 2019

Business Development and Finance

How Early is Too Early? Valuing and De-Risking Preclinical Opportunities

109AB, Level 100

Speakers

Dr. Uwe SchoenbeckSenior VP and Chief Scientific Officer, External R&D atPfizer Inc.

Dr. Kleem ChaudharyHead BD&L MS, AD, OPN, Platforms atBiogen

Michael HostetlerPartner atWilson Sonsini Goodrich and Rosati, P.C.

Lizabeth LeveilleAssociate Vice President and Head, Boston Innovation Hub Business Development & Licensing atMerck

Luc MarengereManaging Partner atTVM Life Science Management Inc

4:30 PM–5:30 PM

Jun 4, 2019

Business Development and Finance

Get Relevant or Go Home: Shedding Light on Oncology R&D Sums

107AB, Level 100

Speakers

Ms. Lisa UrquhartEditor, Vantage atEvaluate Ltd

Curtis HechtChief Business Officer atCalithera Biosciences

Dr. Paul JuniewiczSr. Director, Oncology Search & Evaluation atTakeda

Debi WatsonVice President, Business Development and Licensing atJohnson & Johnson Innovation, Janssen Business Development

11:00 AM–12:00 PM

Jun 5, 2019

Business Development and Finance

Blazing a Trail: Lessons on Bringing a New Technology to Market

109AB, Level 100

Speakers

Peter HennesseyPartner atBallard Spahr LLP

Joseph La BargeChief Legal Officer atSpark Therapeutics

Frank LeonardSVP Corporate Strategy and Health Policy atNovocure

1:45 PM–2:45 PM

Jun 5, 2019

Business Development and Finance

De-Risking Life Sciences Mergers and Acquisitions

109AB, Level 100

Speakers

Frank GoudsmitSVP, Life Sciences atChubb

Ernest KoschinegPartner atCipriani & Werner

Edward MarkovichSVP, Underwriting, Financial Lines atChubb

Ms. Christina ReisingerVice President, Risk Management atLabCorp/Covance

Ms. Karen StrongDirector Risk Management atIntegra LifeSciences

1:45 PM–2:45 PM

Jun 5, 2019

Business Development and Finance

Recognizing Which Assets, Attributes and Resources Drive Deal Success

107AB, Level 100

Speakers

Ben ThornerSenior Vice President & Head, MRL Business Development & Licensing atMerck & Co., Inc.

Mr. Stuart MackeyGlobal Head of Business Development atDaiichi Sankyo

Kush ParmarManaging Partner at5AM Ventures

Aetna Wun TrombleyPresident & Chief Operating Officer atNGM

3:00 PM–4:00 PM

Jun 5, 2019

Business Development and Finance

Deals that Move You: Tips and Tricks for Getting Results

107AB, Level 100

Speakers

Dr. Helen TorleyPresident & Chief Executive Officer atHalozyme Therapeutics

Mr. Paul BiondiHead of Strategy and Business Development atBristol-Myers Squibb

Rachna KhoslaVice President, Business Development atAmgen

Dr. Sophie KornowskiSenior Partner atGurnet Point Capital

Aradhana SarinChief Strategy & Business Officer atAlexion Pharmaceuticals, Inc.

3:00 PM–4:00 PM

Jun 5, 2019

Business Development and Finance

Technology-Based Economic Development: Evolving Models, Strategies and Finance Approaches

109AB, Level 100

Speakers

Dan BerglundPresident and CEO atState Science & Technology Institute

Doug EdgetonPresident and CEO atNorth Carolina Biotechnology Center

Dr. Anthony GreenVice President of Technology Commercialization atBen Franklin Technology Partners

Travis McCreadyPresident and CEO atMassachusetts Life Science Center

9:00 AM–10:15 AM

Jun 6, 2019

Business Development and Finance

Family Offices, Foundations, Impact Investors, and Venture Accelerators: How They Play the Game

107AB, Level 100

Speakers

Gail GannonManaging Director atWaveEdge Capital

Deanna BelskyAssociate atDolby Family Ventures

Christian BraemerCEO/Co-Founder atBenefunder

Alex KopelyanProgram Director & Partner atIndieBio

Tom McKenzieCOO atCavendish Global

10:30 AM–11:45 AM

Jun 6, 2019

Business Development and Finance

The Evolving Landscape of Venture Capital

107AB, Level 100

Speakers

Dr. Mankit LawSenior Associate atPappas Capital

Jennifer HuAdvant VC Investment and BD&L atAdvisor

Dr. Emmanuel LacroixPartner atUCB Ventures

Dr. Jim TrenkleVice President atPivotal Bioventure Partners